Test ID: APO2K
Apolipoprotein A-II (APOA2) Gene, Known Mutation
NY State Approved 
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Conditional
Useful For Suggests clinical disorders or settings where the test may be helpful
Testing individuals at risk for apolipoprotein A-II-associated amyloidosis when a mutation has been identified in an affected family member
Genetics Test Information Provides information that may help with selection of the correct test or proper submission of the test request
Documentation of the specific familial mutation(s) must be provided with the specimen in order to perform this test.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Polymerase Chain Reaction (PCR) Followed by DNA Sequence Analysis
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
APOA2 Gene, Known Mutation
Aliases Lists additional common names for a test, as an aid in searching
APOA2
APOAII
Apolipoprotein A-II
Amyloidosis
APOAII
Apolipoprotein A-II
Amyloidosis
External
link
PDF
document
Excel
document
Word
document